Background. The number of lymph nodes examined during colon cancer surgery falls below nationally recommended guidelines in the general population, with Blacks and Hispanics less likely to have adequate nodal evaluation in comparison to Whites. The Department of Defense's (DoD) Military Health System (MHS) provides equal access to medical care for its beneficiaries, regardless of racial/ethnic background. This study aimed to investigate whether racial/ethnic treatment differences exist in the MHS, an equal-access medical care system. Methods. Linked data from the DoD cancer registry and administrative claims databases were used and included 2,155 colon cancer cases. Multivariate logistic regression assessed the association between race/ethnicity and the number of lymph nodes examined (\12 and C12) overall and for stratified analyses. Results. No overall racial/ethnic differences in the number of lymph nodes examined was identified. Further stratified analyses yielded similar results, except potential racial/ ethnic differences were found among persons with poorly differentiated tumors, where non-Hispanic Blacks tended to be less likely to have C12 lymph nodes dissected (odds ratio 0.34; 95 % confidence interval 0.14-0.80; p = 0.01) compared with non-Hispanic Whites. Conclusion. Racial/ethnic disparities in the number of lymph nodes evaluated among patients with colon cancer were not apparent in an equal-access healthcare system. However, among poorly differentiated tumors there might be racial/ethnic differences in nodal yield, suggesting the possible effects of factors other than access to healthcare.
ABSTRACT
Background. The number of lymph nodes examined during colon cancer surgery falls below nationally recommended guidelines in the general population, with Blacks and Hispanics less likely to have adequate nodal evaluation in comparison to Whites. The Department of Defense's (DoD) Military Health System (MHS) provides equal access to medical care for its beneficiaries, regardless of racial/ethnic background. This study aimed to investigate whether racial/ethnic treatment differences exist in the MHS, an equal-access medical care system. Methods. Linked data from the DoD cancer registry and administrative claims databases were used and included 2,155 colon cancer cases. Multivariate logistic regression assessed the association between race/ethnicity and the number of lymph nodes examined (\12 and C12) overall and for stratified analyses. Results. No overall racial/ethnic differences in the number of lymph nodes examined was identified. Further stratified analyses yielded similar results, except potential racial/ ethnic differences were found among persons with poorly differentiated tumors, where non-Hispanic Blacks tended to be less likely to have C12 lymph nodes dissected (odds ratio 0.34; 95 % confidence interval 0.14-0.80; p = 0.01) compared with non-Hispanic Whites. Conclusion. Racial/ethnic disparities in the number of lymph nodes evaluated among patients with colon cancer were not apparent in an equal-access healthcare system. However, among poorly differentiated tumors there might be racial/ethnic differences in nodal yield, suggesting the possible effects of factors other than access to healthcare.
Colorectal cancer (CRC) is the third leading cause of cancer death in the US. 1 The American Cancer Society estimated that 136,830 incident cases and 50,310 deaths will occur in 2014 due to CRC, with almost three-quarters (71 %) of incident cases occurring in the colon. 2 Lymph node metastasis is an important predictor of survival among colon cancer patients. 3, 4 The dissection of a sufficient number of lymph nodes is emphasized in order to predict nodal status (positive versus negative), thus assuring accurate staging of disease and the evaluation of lymph node metastasis. 5, 6 The number of lymph nodes evaluated has also been positively correlated with survival, [7] [8] [9] which is likely explained by the increasing use of adjuvant therapy upon detection of positive lymph nodes, which in turn depends on lymph node yield. 10 Therefore, the number of lymph nodes evaluated is an important clinical and prognostic factor for colon cancer.
National guidelines recommend that at least 12 lymph nodes be resected surgically and examined pathologically in patients with colon cancer. [11] [12] [13] Despite these promulgated guidelines, studies have indicated that compliance remains suboptimal 7, 14, 15 and can vary according to patient factors (e.g. age or obesity), [16] [17] [18] tumor factors (e.g. tumor stage and site), 14, 18, 19 and physician factors (e.g. patient volume and years of experience). 15 Recent studies, although inconsistent, 20, 21 suggested that the number of lymph nodes dissected may vary by race/ethnicity. beneficiaries, Hispanics were also found to have less adequate nodal yield in comparison to Whites. 25, 26 Previous studies might be influenced by unequal access to medical care, a health disparity in which medical care is not equivalent amongst different individuals due to factors such as race/ethnicity. Unequal access to healthcare due to insufficient health insurance affects not only the receipt of needed care but also the quality of care. 27 Individuals with less access to care are less likely to receive needed services and recommended care. 27 Minorities are more likely to have insufficient health insurance [28] [29] [30] and thus receive poorer quality healthcare. 30 For example, Blacks are less likely to have access to high-volume hospitals or surgeons [31] [32] [33] and to receive surgeries [34] [35] [36] than Whites. Therefore, it is possible that racial/ethnic differences in the extent of lymph node evaluation may at least partially be accounted for by unequal access to medical care. Such inequity between racial/ethnic groups may be reduced in an equal-access system.
To the best of our knowledge, no previous studies have examined racial/ethnic disparities in lymph node retrieval in an equal-access setting; such studies in healthcare disparity help assess the potential influences of unequal access to care on the possible racial/ethnic differences as well as the possible effects of factors other than access to care. The Department of Defense's (DoD) Military Health System (MHS) provides equal access to medical care for its beneficiaries regardless of their racial/ethnic background, offering an excellent opportunity to investigate racial/ethnic differences in the number of lymph nodes resected and evaluated among colon cancer patients.
The objective of this study was to examine the number of lymph nodes resected surgically and examined pathologically among non-Hispanic White (NHW), nonHispanic Black (NHB), Asian/Pacific Islanders (API), and Hispanic White (HW) colon cancer patients in the MHS. Furthermore, we assessed whether racial/ethnic differences in lymph node yield varied by age at diagnosis, sex, tumor stage, tumor grade, and colon cancer site.
MATERIALS AND METHODS

Data Source
This study utilized linked and consolidated data from the DoD's Central Cancer Registry (CCR) and the MHS Data Repository (MDR). Information from DoD beneficiaries, including active-duty members, retirees, Guards and Reserve members and their dependants, are contained in both data sources. For CCR, certified cancer registrars abstract demographic, health, and tumor characteristic information from the records of cancer patients diagnosed and/or treated at military treatment facilities (MTFs) according to the North American Association of Central Cancer Registries guidelines. The MDR contains administrative and medical care claims information, which includes clinical diagnosis, diagnostic procedures, treatment, health conditions, and medical prescriptions, from the DoD heathcare program, known as Tricare, for inpatient and outpatient services provided either at MTFs (direct care) or at civilian facilities paid for by the DoD (indirect care).
The 
Study Variables
Tumor characteristics, including the number of lymph nodes examined, were obtained from the CCR. According to national colon cancer guidelines, a minimum of 12 lymph nodes should be dissected. [11] [12] [13] Therefore, the total number of regional lymph nodes removed and examined, which was obtained from the variable 'regional nodes examined', was classified into two groups: \12 lymph nodes and C12 lymph nodes. Tumor stage was categorized as Stage I, Stage II, and Stage III based on the American Joint Committee on Cancer staging recommendations. 37 Tumor histologic grade was classified, based on the level of differentiation, as well differentiated, moderately differentiated, poorly differentiated, and unknown. Colon cancer site was categorized into four categories: right (C180, 182, 183: cecum, ascending colon, hepatic flexure, respectively), transverse (C184), left (C185-187: splenic flexure, descending colon, and sigmoid colon, respectively), and overlapping/unknown (C188, 189).
Demographic characteristics were obtained from the CCR, with missing information supplemented from the MDR. Race/ethnicity was categorized into four groups: NHW, NHB, API, and HW. Other demographic information included diagnosis year, age at diagnosis, sex, marital status, active-duty status, military service branch, military healthcare benefit type, and military rank. Based on the release of national guidelines, [11] [12] [13] diagnostic years were divided into three periods: 1998-2000, 2001-2003, and 2004-2007 . Age at diagnosis was categorized into four groups: 20-49 years, 50-59 years, 60-69 years, and 70? years. Marital status included being never married, married, other (separated, divorced, or widowed), and unknown. Beneficiaries were classified as either active duty or non-active duty (i.e. retiree and dependants) at the time of their diagnosis. The service branch of the activeduty member or sponsor was categorized as Army, Air Force, Navy/Marines, other (i.e. Coast Guard and Public Health Service), and unknown. Benefit type was classified into three categories: TRICARE Prime (Health Maintenance Organization-like component), not Prime, and unknown. The military rank of the active-duty member or sponsor, which was used as a surrogate for income, included enlisted personnel, officer, other (i.e. civilian pay plan, general schedule, non-appropriated funds), and unknown.
Information on obesity was obtained from the MDR. Patients who had an ICD, Ninth Revision (ICD-9) diagnostic code of 278.00 or 278.01 were identified as being obese.
Statistical Analysis
As the first step of data analysis, the overall racial and ethnic differences between demographic and tumor characteristics were compared using Chi-square tests of significance. We then assessed the association between race/ethnicity and the number of lymph nodes examined (\12 and C12) using multivariate logistic regression, adjusting for potential confounders that included demographic variables, tumor characteristics, and obesity. Finally, we analyzed whether the relationship between race/ethnicity and the number of lymph nodes examined varied by age at diagnosis, sex, tumor stage, tumor grade, and colon cancer site. Odds ratios (OR) and 95 % confidence intervals (CI) were calculated for overall and stratified analyses. Since the number of lymph nodes examined has been found to be associated with obesity, 16 all aforementioned analyses were rerun excluding all patients who were identified as being obese.
Tests of significance were two-tailed and conducted at an alpha of 0.05 using Statistical Analysis System (SAS) software, Version 9.3 for Windows (SAS Institute, Inc., Cary, NC, USA).
RESULTS
This study included 2,155 beneficiaries with colon cancer who received care from the MHS (1,530 NHWs, 350 NHBs, 169 APIs, and 106 HWs) ( Table 1 ). The overall proportion of patients having at least 12 lymph nodes examined was 59 %. The distributions of factors, except year of diagnosis, marital status, and tumor grade, varied among racial/ethnic groups (p \ 0.05). The number of lymph nodes examined also did not differ by race/ethnicity, with 57.5 % NHWs, 62.3 % NHBs, 57.4 % APIs, and 65.1 % HWs receiving an adequate lymph node evaluation (p = 0.20). At the time of colon cancer diagnosis, NHWs tended to be older, an officer/having a sponsor who was an officer, and have earlier stage disease than minority groups. NHW, NHB, and HW patients were more likely to be men, while APIs were more likely to be women. NHBs were more likely to be an active-duty member of the military and obese than other races/ethnicities. NHWs were more likely to be affiliated with the Air Force, whereas NHBs and HWs were more likely to be affiliated with the Army. NHBs and APIs were more likely to have Tricare Prime insurance than NHWs and HWs. While NHWs and NHBs tended to have right-sided colon cancers, APIs and HWs tended to be diagnosed with left-sided colon cancers.
After adjustment for potential confounding factors, NHBs, HWs, and APIs were not significantly different from NHWs in receiving adequate lymph node evaluation ( Table 2) . Racial/ethnic differences in the number of lymph nodes examined were also not observed when analyses were further stratified by age at diagnosis, sex, tumor stage, and colon cancer site (data for age at diagnosis and sex not shown). Furthermore, the number of lymph nodes examined did not differ by race/ethnicity among patients with well or moderately differentiated tumors. In contrast, among patients with poorly differentiated tumors, significant differences between NHBs and NHWs in nodal yield were observed. NHBs were less likely to have C12 lymph nodes examined compared with NHWs (OR 0.34, 95 % CI 0.14-0.80, p = 0.01). Among APIs and HWs, no significant differences in the number of lymph nodes examined was found in comparison to NHWs (OR 0.82, 95 % CI 0.26-2.54, p = 0.72; OR 1.14, 95 % CI 0.25-5.28, p = 0.87, respectively).
DISCUSSION
This study showed that the overall proportion of patients with C12 lymph nodes resected and examined (59 %) was higher than in the general population (44 % among patients in Louisiana and 38 % among patients examined in SEERMedicare). 22, 26 Unlike previous studies that found racial/ ethnic differences in the number of lymph nodes examined, 22, 23, 25, 26 this study observed no overall differences in the number of lymph nodes examined among NHW, NHB, API, and HW beneficiaries with equal access to healthcare in the MHS. We also did not observe racial/ethnic differences by age at diagnosis, sex, tumor stage, or colon cancer site. However, among patients with poorly differentiated tumors, potential racial/ethnic differences in the number of lymph nodes examined were observed.
Our findings suggest that the racial/ethnic differences in the number of lymph nodes evaluated in the general population might be minimal within the DoD equal-access healthcare system; however, we cannot exclude the possibility of racial/ethnic differences among patients with poorly differentiated cancer. Larger studies within an equal-access system are needed to demonstrate whether different racial/ethnic groups differ in the number of lymph nodes evaluated, particularly for certain subgroups such as poorly differentiated tumors and other potential effect modifiers (e.g. microsatellite instability/mismatch repair (MSI/MMR) 38, 39 ) that could not be assessed in this data. It is not clear why the racial difference was observed only for poorly differentiated tumors. While it might result from chance alone, factors other than access to care might play a role. For example, obesity, which may vary between different racial/ethnic groups, has been found to be associated with lymph node yield. 16 Blacks and Hispanics tend to be more obese than NHWs. 40 The presence of fatty tissue causes the retrieval of lymph nodes to be more difficult due to technical complexity of lymph node dissection, as shown by increased surgical time, 41 among obese patients. However, obesity was adjusted for in our data analysis. Furthermore, when the analyses were confined to patients without obesity, the results remained similar (data not shown). Thus, obesity might not account for the observed racial difference among patients with poorly differentiated tumors.
Lymph node yield may also be influenced by physician factors. Adequate lymph node yield has been associated with surgeon procedure volume, with high-volume surgeons, who tend to have more experience, harvesting more lymph nodes compared with low-volume surgeons. 15, [42] [43] [44] The skill level of a pathologist may also play a role in the retrieval of more lymph nodes, particularly when lymph node harvest is performed by a staff pathologist compared with a pathology resident/technologist. 15 However, studies have found that pathology assistants, who often have more time and fewer distractions, harvest more lymph nodes than more experienced pathologists. 45, 46 It is not known if the physician factors varied between NHB and NHW patients in our study population.
This study had several strengths. First, it minimized the potential effects of unequal access to care on racial/ethnic differences. Second, to our knowledge, it is the first study that assessed racial/ethnic differences in lymph node evaluation by demographic or tumor characteristics, although other biological indicators such as MSI/MMR tumor status could not be analyzed. The study also had limitations. The numbers of patients in certain strata were comparatively small, which prevented us from having solid evidence on whether racial/ethnic differences in the number of lymph nodes evaluated existed in certain groups defined by age at diagnosis, sex, tumor stage, tumor grade, and colon cancer site. For example, for stage I cancer, the that may be related to lymph node retrieval and examination. Thus, we were unable to assess whether these physician factors might have affected our results. Lastly, the use of information from medical and administrative claims databases could result in coding errors and incomplete data. However, the combined use of data from the cancer registry minimized the likelihood of this limitation.
CONCLUSIONS
Racial/ethnic disparities in the number of lymph nodes examined among NHWs, NHBs, APIs, and HWs were not apparent in an equal-access healthcare system. However, racial/ethnic differences in nodal evaluation could potentially vary by tumor grade, with a lower frequency of sufficient lymph nodes examined among NHBs with poorly differentiated tumor grade. These results suggest the possibility that other factors, in addition to access to healthcare, might play a role in the racial/ethnic disparities seen in the general population. 
